Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Northsight Capital Appoints CEO

This article was originally published in Scrip

Executive Summary

Northsight Capital Inc. has appointed John B. Hollister CEO. Hollister has over 25 years of commercial management and fundraising experience and held roles at various companies including SmithKline Beecham and Amgen, where he was director and global commercial leader in oncology. Most recently he was CEO and director of NEMUS Bioscience and previously was CEO and chair of medical device company, EGG Spectrum International. He was also senior vice-president for a diagnostic company, Tethys Bioscience.

Topics

Related Companies

UsernamePublicRestriction

Register

SC030150

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel